-
公开(公告)号：US06873741B2
公开(公告)日：2005-03-29
申请号：US10043759
申请日：2002-01-10
Applicant: Xin Li
Inventor： Xin Li
CPC classification number: G06T5/002 , G06T5/003 , G06T5/20 , G06T2207/20192
Abstract: Methods and apparatus for digital data array edge enhancement are disclosed. A local data window containing a data sample s is selected. Minimum and maximum sample values, max and min, are located within the window, and an edge deflection value ed is defined to have a value between max and min. A diffusion quantity is then calculated to move the value of s towards max, if s is greater than ed, or towards min, if s is smaller than ed. This approach has advantages over gradient-based edge-enhancement, including simplicity, convergence speed, and stability.
Abstract translation: 公开了用于数字数据阵列边缘增强的方法和装置。 选择包含数据样本s的本地数据窗口。 最小和最大采样值max和min位于窗口内，边缘偏移值ed定义为max和min之间的值。 然后，如果s小于ed，则计算扩散量，将s的值移动到max，如果s大于ed，或者如果s小于ed则将其移动到min。 这种方法比基于梯度的边缘增强具有优势，包括简单性，收敛速度和稳定性。
-
公开(公告)号：US06865298B2
公开(公告)日：2005-03-08
申请号：US09823399
申请日：2001-03-30
Applicant: Xin Li
Inventor： Xin Li
CPC classification number: G06T9/005
Abstract: A method for compression of compound images. The method determines a classification for a current pixel based upon its causal neighbors and codes the pixel according to a mode determined by the classification. This coding results in production of a symbol for the pixel and the symbol is then mapped to the output stream.
Abstract translation: 一种压缩复合图像的方法。 该方法基于其因果邻居确定当前像素的分类，并根据由分类确定的模式对像素进行编码。 该编码导致生成像素的符号，然后将符号映射到输出流。
-
公开(公告)号：US12236062B2
公开(公告)日：2025-02-25
申请号：US17752773
申请日：2022-05-24
Applicant: Chian Chiu Li , Xin Li
Inventor： Chian Chiu Li , Xin Li
IPC: G06F3/0484 , G06F3/16 , G06K7/14 , G06Q30/0601
Abstract: Systems and methods for performing a task via a simple code. Combination of a marker and a simple code represents a task. In an aspect, after a code is received, possible objects are determined and presented. After a user selects a possible object, a task related to the object is performed. In another aspect, a task is performed when a voice input contains a code and a user gazes or gestures at a device.
-
公开(公告)号：USD997416S1
公开(公告)日：2023-08-29
申请号：US29813850
申请日：2021-11-02
Applicant: Xin Li
Designer： Xin Li
Abstract: FIG. 1 is a front, top and right side perspective view of a desk lamp, showing my new design;
FIG. 2 is a front view thereof;
FIG. 3 is a rear view thereof;
FIG. 4 is a right side view thereof;
FIG. 5 is a left side view thereof;
FIG. 6 is a top plan view thereof; and,
FIG. 7 is a bottom plan view thereof.
The broken lines shown in the drawings depict portions of the desk lamp which form no part of the claimed design.-
公开(公告)号：US20210027781A1
公开(公告)日：2021-01-28
申请号：US17067681
申请日：2020-10-10
Applicant: Chian Chiu Li , Xin Li
Inventor： Chian Chiu Li , Xin Li
Abstract: Systems and methods for performing a task via a simple code. Combination of a unique marker and a simple code represents a task. A simple code is submitted manually or by a voice input. Voice recognition and gesture recognition are used. In an aspect, a task is executed when a voice input comprises a predetermined name and a simple code. In another aspect, a task is executed when a voice input comprises a simple code and a user gazes or gestures at a device.
-
Patent Agency Ranking
公开(公告)号：US10335048B2
公开(公告)日：2019-07-02
申请号：US14543071
申请日：2014-11-17
Applicant: William Rooney , Charles Springer, Jr. , Xin Li
Inventor： William Rooney , Charles Springer, Jr. , Xin Li
IPC: A61B5/055 , A61B5/0265 , G01R33/563 , A61B5/0295 , A61B5/026 , A61B5/00 , G01R33/48 , G01R33/50 , G01R33/56
Abstract: Provided herein are methods and apparatuses for determining a level of cellular metabolic activity for a region of interest in order to detect and map on-going gliovascular unit metabolic activity using high-resolution 1H2O MRI. In one example approach, a computer-implemented method includes receiving a first set of DCE-MRI time-course data for a region, wherein a contrast agent is administered prior to imaging, identifying a region of interest from the first set of DCE-MRI time-course data for further analysis, performing shutter-speed pharmacokinetic analysis of the time-course data associated with the region of interest using computer-implemented software to obtain a finite and non-zero mean water molecule capillary lifetime in the region of interest, and indicating a level of cellular metabolic activity in the brain based on the mean water molecule capillary lifetime.
-
127.发明授权公开(公告)号：US10084169B2
公开(公告)日：2018-09-25
申请号：US14443391
申请日：2011-11-01
Applicant: Xin Li , Jianhua Li , Wei Chen , Yongjun Jiao , Long Li , Xinjian Deng
Inventor： Xin Li , Jianhua Li , Wei Chen , Yongjun Jiao , Long Li , Xinjian Deng
IPC: H01M2/16 , H01M2/14 , H01M2/18 , H01M10/0525 , H01M10/42
CPC classification number: H01M2/1686 , H01M2/145 , H01M2/1653 , H01M2/166 , H01M2/18 , H01M10/0525 , H01M10/4235 , H01M2220/30
Abstract: A lithium ion battery separator consists of a PE micro-porous substrate A and a micro-porous coating B which is located on the substrate A and formed of mixing pre-crosslinked rubber particles and ceramic fine powder composite materials. The separator has characteristics of good compressible elasticity, thermal shutdown, low heat shrinkage, high temperature membrane rupture resistance and so on.
-
公开(公告)号：US09260384B2
公开(公告)日：2016-02-16
申请号：US13697888
申请日：2010-05-14
Applicant: Kunlun He , Song Li , Wu Zhong , Juan Liu , Lili Wang , Xin Li , Guoliang Hu , Long Long , Junhai Xiao , Zhibing Zheng , Wei Li , Ruijun Li , Chunlei Liu , Jie Bai
Inventor： Kunlun He , Song Li , Wu Zhong , Juan Liu , Lili Wang , Xin Li , Guoliang Hu , Long Long , Junhai Xiao , Zhibing Zheng , Wei Li , Ruijun Li , Chunlei Liu , Jie Bai
IPC: A61K31/47 , C07C275/28 , C07D215/40
CPC classification number: C07C275/28 , C07D215/40
Abstract: A compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof, is provided. Also, a composition containing a compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents, is provided. Further, use of a compound of Formula I, or an isomer, pharmaceutically acceptable salt or solvate thereof for anti-apoptosis is provided, preventing or treating a disease or disorder associated with apoptosis; especially for protecting cardiomyocyte, preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.
Abstract translation: 提供式I化合物或其异构体，药学上可接受的盐或溶剂合物。 此外，还提供含有式I化合物或其异构体，药学上可接受的盐或溶剂合物，以及药学上可接受的载体，赋形剂或稀释剂的组合物。 此外，提供了式I化合物或其异构体，其药学上可接受的盐或溶剂合物用于抗凋亡的用途，用于预防或治疗与凋亡相关的疾病或病症; 特别是用于保护心肌细胞，预防或治疗与心肌细胞凋亡相关的疾病或病症。
-
公开(公告)号：US09199978B2
公开(公告)日：2015-12-01
申请号：US13697810
申请日：2010-05-14
Applicant: Kunluu He , Song Li , Wu Zhong , Juan Liu , Lili Wang , Xin Li , Guoliang Hu , Jie Wang , Long Long , Junhai Xiao , Zhibing Zheng , Wei Li , Ruijun Li , Chunlei Liu , Jie Tang
Inventor： Kunluu He , Song Li , Wu Zhong , Juan Liu , Lili Wang , Xin Li , Guoliang Hu , Jie Wang , Long Long , Junhai Xiao , Zhibing Zheng , Wei Li , Ruijun Li , Chunlei Liu , Jie Tang
IPC: A61K31/5377 , C07D295/194 , C07D295/21 , C07D409/12 , A61K31/17 , A61K31/381 , A61K31/435 , A61K31/4709 , A61K31/496 , C07C335/12 , C07D333/24
CPC classification number: A61K31/18 , A61K31/17 , A61K31/381 , A61K31/435 , A61K31/4453 , A61K31/4709 , A61K31/496 , A61K31/5375 , A61K31/5377 , C07C335/12 , C07D295/194 , C07D295/21 , C07D333/24 , C07D409/12
Abstract: The present invention relates to a compound of Formula I, or an isomer, pharmaceutically acceptable salt and solvate of the compound, and to a composition comprising the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof, and a pharmaceutically acceptable carrier, excipient or diluents. The present invention also relates to use of the compound of Formula I, or the isomer, pharmaceutically acceptable salt and solvate thereof for combating apoptosis, preventing or treating a disease or disorder associated with apoptosis; and especially use for protecting cardiomyocyte, and for preventing or treating a disease or disorder associated with cardiomyocyte apoptosis.
Abstract translation: 本发明涉及式I化合物或其化合物的异构体，药学上可接受的盐和溶剂合物，以及包含式I化合物或其异构体，药学上可接受的盐和溶剂化物的组合物和药学上可接受的 载体，赋形剂或稀释剂。 本发明还涉及式I化合物或其异构体，药学上可接受的盐和溶剂合物用于防治凋亡，预防或治疗与凋亡相关的疾病或病症的用途; 特别是用于保护心肌细胞，并用于预防或治疗与心肌细胞凋亡相关的疾病或病症。
-
-
-
-
-
-
-
-
-
Search Results
214
records
(took 0.023 seconds)
